Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking semaglutide and aspirin together is generally considered safe — there is no known pharmacokinetic interaction between the two medicines, and aspirin is not listed as a contraindication in the semaglutide prescribing information. That said, both drugs can affect the stomach, and the full picture is worth understanding before you combine them. As a prescription-only medicine, semaglutide requires clinical assessment before it is prescribed; your prescriber is the right person to review everything you already take.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This one circulates a lot, usually rooted in a reasonable but imprecise worry. Semaglutide slows how quickly the stomach empties its contents into the small intestine, so people assume it must interfere with every oral medicine, including aspirin. The slowing is real; the blanket ban is not.
The licensed prescribing information for Wegovy (the weight-management form of semaglutide) does not list aspirin as a contraindicated or significantly interacting medicine. The BNF entry for semaglutide identifies a small number of specific interactions to monitor, aspirin at standard analgesic or low-dose cardioprotective doses is not among them. If you have been told definitively that combining the two is prohibited, it is worth asking where that guidance came from, because the published evidence does not support that conclusion.
What the evidence does support is a more nuanced picture: the combination is not flagged as dangerous, but it does put two gut-active medicines together in the same body. Understanding why that matters is more useful than a blanket rule either way. Our page on aspirin and Wegovy goes into the specific Wegovy context if you want to read further there.
Semaglutide activates GLP-1 receptors in the gut wall and central nervous system, which among other effects slows the rate at which your stomach moves food and medicine into the small intestine. For most drugs this matters very little in practice, because the overall amount absorbed tends to stay roughly the same, just spread across a slightly longer window. The NHS medicines page for semaglutide notes this effect and advises telling a pharmacist or prescriber about all medicines you take so that anything time-sensitive can be managed appropriately.
Aspirin is absorbed primarily in the small intestine rather than the stomach, so a modest delay in gastric emptying is unlikely to meaningfully reduce how much aspirin your body takes up. The situation is different for medicines where peak concentration timing is clinically critical, certain oral contraceptives are one example discussed in the semaglutide SmPC, which is why additional contraceptive precautions are sometimes advised. Aspirin does not share that sensitivity in the same way.
Where the combination deserves attention is on the stomach lining itself. Aspirin inhibits prostaglandin synthesis, which reduces the stomach's natural protective mucus layer. Semaglutide commonly causes nausea, reflux and stomach discomfort, particularly in the first weeks of treatment or after a dose increase. If you are taking aspirin regularly (whether for pain relief or as low-dose cardioprotection) those effects can feel amplified simply because your gut is already adjusting to semaglutide. This is not an interaction in the pharmacological sense; it is two separate mechanisms landing in the same place at the same time.
The practical upshot is straightforward. Tell your prescriber and your GP that you take aspirin, whether that is 75 mg daily for heart protection or a higher dose for pain. If you are exploring how semaglutide interacts with other drugs more broadly, the same principle applies across the board: a complete medicine list matters more than any single yes-or-no answer.
If you experience significant stomach pain, nausea or reflux after starting semaglutide whilst taking aspirin, that is worth flagging to a clinician rather than pushing through. Taking aspirin with food (where your dose schedule allows) can reduce gastric irritation. Proton pump inhibitors are sometimes already prescribed alongside regular aspirin for exactly this reason, your prescriber can advise whether that applies to you.
The wider picture of Wegovy drug interactions covers medicines where the clinical guidance is more specific, including those requiring closer monitoring, and our dedicated page on interactions with Wegovy is a useful companion if you want a fuller overview of what to discuss with your prescriber. For the cost side of treatment, Wegovy pricing in the UK sets out what private prescriptions typically involve.
A question our prescribers hear regularly is whether patients need to stop low-dose aspirin before starting weight-loss treatment. In most cases the answer is no, but that decision belongs with the clinician who can see your full medical history, not with a general information page. If you are ready to have that conversation, starting your free consultation is the right next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.